In neonatal cholestasis, if the serum gamaglutamyl-transpeptidase (gamma GTP) is more than 600IU/L the most likely diagnosis is:
## **Core Concept**
Neonatal cholestasis refers to a condition in newborns where there is a reduction or stoppage of bile flow, leading to the accumulation of bile salts in the liver and bloodstream. Gamma-glutamyl transpeptidase (gamma-GTP or GGT) is an enzyme found in many organs, particularly in the liver, and is often elevated in conditions affecting the biliary system.
## **Why the Correct Answer is Right**
The correct answer, **D. Biliary atresia**, is suggested when serum GGT levels are significantly elevated, particularly above 600 IU/L, in the context of neonatal cholestasis. Biliary atresia is a condition characterized by the obstruction or absence of bile ducts, which leads to cholestasis. A hallmark of biliary atresia is the significant elevation of GGT, often more than 600 IU/L, due to the obstruction of bile flow which causes a marked increase in the production of this enzyme.
## **Why Each Wrong Option is Incorrect**
- **Option A:** While alpha-1 antitrypsin deficiency can cause neonatal cholestasis, it typically presents with low levels of alpha-1 antitrypsin and abnormal liver histology, not specifically with GGT levels over 600 IU/L.
- **Option B:** Neonatal hepatitis can cause elevated liver enzymes, including GGT, but the levels are usually not as high as those seen in biliary atresia.
- **Option C:** Choledochal cysts can cause obstructive jaundice and elevated GGT but are less commonly associated with GGT levels exceeding 600 IU/L compared to biliary atresia.
## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that a GGT level greater than 600 IU/L in a neonate with cholestasis is highly suggestive of **biliary atresia**. Early diagnosis of biliary atresia is critical because it requires prompt surgical intervention (Kasai procedure) to restore bile flow and prevent further liver damage.
## **Correct Answer: D. Biliary atresia**